Your browser doesn't support javascript.
loading
Corrigendum to "European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines" [Eur. Urol. 85 (2024) 17-31].
Alfred Witjes, J; Bruins, Harman Max; Carrión, Albert; Cathomas, Richard; Compérat, Eva; Efstathiou, Jason A; Fietkau, Rainer; Gakis, Georgios; Lorch, Anja; Martini, Alberto; Mertens, Laura S; Meijer, Richard P; Milowsky, Matthew I; Neuzillet, Yann; Panebiaco, Valeria; Redlef, John; Rink, Michael; Rouanne, Mathieu; Thalmann, George N; Sæbjørnsen, Sæbjørn; Veskimäe, Erik; Mariappan, Paramananthan; van der Heijden, Antoine G.
Afiliación
  • Alfred Witjes J; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. Electronic address: fred.witjes@radboudumc.nl.
  • Bruins HM; Department of Urology, Zuyderland Medisch Centrum, Sittard/Heerlen, The Netherlands.
  • Carrión A; Department of Urology, Vall Hebron Hospital, Autonomous University of Barcelona, Barcelona, Spain.
  • Cathomas R; Department of Medical Oncology, Kantonsspital Graubünden, Chur, Switzerland.
  • Compérat E; Department of Pathology, Medical University Vienna General Hospital, Vienna, Austria.
  • Efstathiou JA; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Fietkau R; Department of Radiation Therapy, University of Erlangen, Erlangen, Germany.
  • Gakis G; Department of Urology and Pediatric Urology, University of Würzburg, Würzburg, Germany.
  • Lorch A; Department of Medical Oncology and Hematology, University Hospital Zürich, Zürich, Switzerland.
  • Martini A; Department of Urology, Institut Universitaire du Cancer-Toulouse-Oncopole, Toulouse, France; Department of Urology, MD Anderson Cancer Center, Houston, TX, USA.
  • Mertens LS; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Meijer RP; Department of Oncological Urology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Milowsky MI; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Neuzillet Y; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.
  • Panebiaco V; Department of Radiological Sciences, Oncology and Pathology, Sapienza University of Rome, Rome, Italy.
  • Redlef J; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Rink M; Department of Urology, Marienkrankenhaus Hamburg, Hamburg, Germany.
  • Rouanne M; Department of Urology, Foch Hospital, University of Versailles-Saint-Quentin-en-Yvelines, Suresnes, France.
  • Thalmann GN; Department of Urology, Inselspital, University Hospital Bern, Bern, Switzerland.
  • Sæbjørnsen S; Patient Representative, European Association of Urology Guidelines Office, Arnhem, The Netherlands.
  • Veskimäe E; Department of Urology, Tampere University Hospital, Tampere, Finland.
  • Mariappan P; Edinburgh Bladder Cancer Surgery (EBCS), Western General Hospital, University of Edinburgh, Edinburgh, The United Kingdom.
  • van der Heijden AG; Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
Eur Urol ; 85(6): e180, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38492977
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Eur Urol / Eur. urol / European urology (Online) Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Eur Urol / Eur. urol / European urology (Online) Año: 2024 Tipo del documento: Article